Intended for international use only. Indications for use of products and/or therapies contained herein may not be cleared /approved for use by the following Health international agencies: US Food & Drug Administration, Health Canada or Japanese Health Ministry. To access the specific information of your market, use the country selector located on the top menu of this page.
BTI solutions for Transverse Atrophy
BTI offers professionals specific solutions that enable them to approach the treatment of severely resorbed atrophic maxillae with predictable surgical techniques that are less invasive and barely traumatic.